Aslan Pharmaceuticals Ltd
NASDAQ:ASLN
Aslan Pharmaceuticals Ltd
Pre-Tax Income
Aslan Pharmaceuticals Ltd
Pre-Tax Income Peer Comparison
Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors
Company | Pre-Tax Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Aslan Pharmaceuticals Ltd
NASDAQ:ASLN
|
Pre-Tax Income
-$11.5m
|
CAGR 3-Years
26%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
See Also
What is Aslan Pharmaceuticals Ltd's Pre-Tax Income?
Pre-Tax Income
-11.5m
USD
Based on the financial report for Sep 30, 2023, Aslan Pharmaceuticals Ltd's Pre-Tax Income amounts to -11.5m USD.
What is Aslan Pharmaceuticals Ltd's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 5Y
15%
Over the last year, the Pre-Tax Income growth was 59%. The average annual Pre-Tax Income growth rates for Aslan Pharmaceuticals Ltd have been 26% over the past three years , 15% over the past five years .